Advanced Drug Sciences (ADS) is an international, peer-reviewed Gold Open Access journal published by Universitas Muhammadiyah Surakarta (UMS), Indonesia. The journal is dedicated to advancing the science of drug discovery, development, and therapeutic application by publishing high-quality, original, and interdisciplinary research.
ADS provides a multidisciplinary platform that integrates pharmaceutical, biomedical, and clinical sciences, with a strong emphasis on mechanistic understanding, technological innovation, and translational relevance.
The journal aims to bridge the continuum from molecular design and formulation to clinical outcomes and population-level health impact.
The journal operates under a Gold Open Access model, ensuring that all accepted articles are immediately and permanently accessible without subscription barriers. Articles are published under a continuous publication model to enable rapid dissemination of scientific findings.
ADS welcomes contributions that advance both fundamental knowledge and practical applications in drug sciences, including, but not limited to, drug discovery and medicinal chemistry, pharmaceutics and advanced drug delivery, pharmacology and pharmacokinetics, biopharmaceuticals and biotechnology-derived therapeutics, and clinical and translational research.
Through rigorous peer review and adherence to internationally recognized ethical standards, ADS is committed to publishing scientifically robust research that contributes to innovation in drug development and the improvement of global healthcare outcomes.
Advanced Drug Sciences is fully sponsored, both technically and financially, by Universitas Muhammadiyah Surakarta. This is to ensure that editorial decisions are based on the suitability of the manuscript for the journal's scope, impact, and overall quality. Universitas Muhammadiyah Surakarta does not influence editorial decision-making.
